Studies have shown that gambogic acid induces apoptosis in imatinib-resistant CML cells through multiple mechanisms, including proteasome inhibition and caspase-dependent downregulation of BCR-ABL protein levels [101]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.